Novartis partner Molecular Partners surges on COVID-19 treatment data
Novartis AG and Molecular Partners AG on Monday reported positive topline data from their antiviral Covid-19 treatment ensovibep, and will seek expedited regulatory authorizations globally.
The ensovibep treatment continues to maintain protection against variants of concern identified so far, including Omicron, the Basel-based drugmaker said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Italy reports 184 COVID-19 deaths on Saturday - Health MinistryItaly reported 197,552 COVID-19 cases on Saturday, up from 108,304 the day before, the health ministry said, while the number of deaths fell to 184 from 223.
Consulte Mais informação »
Restaurants & Bars Hampered By COVID-19 Sickening Workers, Even Closing For Several WeeksRestaurants and bars have struggled during the pandemic as shutdowns and lack of customers have hampered their operations.
Consulte Mais informação »
State Senate Majority Leader Billig tests positive for COVID-19Democratic Senate Majority Leader Andy Billig announced that he has tested positive for COVID-19.
Consulte Mais informação »
UK records more than 150,000 Covid-19 deaths since pandemic beganMore than 150,000 people have died of Covid-19 in the United Kingdom, according to Johns Hopkins University data. A further 313 deaths were reported in the government's daily figures on Saturday, taking the total to 150,057.
Consulte Mais informação »
Why are rapid tests for COVID-19 in such short supply?Given that the U.S. has been experiencing COVID waves for nearly two years, you may be wondering: How did we find ourselves in this situation? Public health experts explain the roots of the shortfall and what might be done to avoid one next time.
Consulte Mais informação »